Registry of Chinese Patients with Marginal Zone Lymphoma
The Effectiveness and Safety of Different Treatment Modalities in Real-World Clinical Practice Among Chinese Patients with Marginal Zone Lymphoma: a Prospective, Observational, Multi-center Study
This study looks at how Chinese patients with marginal zone lymphoma are treated in real life to see how well those treatments work and how they affect patients' quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06534463 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the real-world treatment approaches and their effectiveness and safety for Chinese patients diagnosed with marginal zone lymphoma. It aims to gather data on patient characteristics and assess health-related quality of life. Treatment regimens will be determined by physicians based on standard clinical practices and drug labels in China. The study will provide insights into how marginal zone lymphoma is managed in a real-world setting.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with marginal zone lymphoma who meet the treatment indications.
Not a fit: Patients who do not have marginal zone lymphoma or those deemed unsuitable by the investigator will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of effective treatment strategies for marginal zone lymphoma in Chinese patients.
How similar studies have performed: While this study focuses on a specific population, similar observational studies have successfully provided valuable insights into treatment effectiveness in various cancers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be diagnosed as MZL * Meet the treatment indications for MZL Exclusion Criteria: * Any reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.
Where this trial is running
Shanghai, Shanghai Municipality
- Shanghai Ruijin Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Weili Zhao
- Email: zwl_trial@163.com
- Phone: +862164370045
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.